Cleared Traditional

K933152 - MEROCEL MEROSPLINT

K933152 is the FDA 510(k) clearance for MEROCEL MEROSPLINT by Merocel Corp.. It is a Class 1 Ear, Nose, Throat device (product code LYA) cleared through the Traditional 510(k) pathway after a 49-day FDA review.

K933152 · Merocel Corp. · Ear, Nose, Throat device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1993
Decision
49d
Days
Class 1
Risk

K933152 is an FDA 510(k) clearance for the MEROCEL MEROSPLINT. Classified as Splint, Intranasal Septal (product code LYA), Class I - General Controls.

Submitted by Merocel Corp. (Mystic, US). The FDA issued a Cleared decision on August 17, 1993 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Ear, Nose, Throat FDA review panel, regulated under 21 CFR 874.4780 - the FDA ear, nose and throat device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Merocel Corp. devices

Submission Details

510(k) Number K933152 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 1993
Decision Date August 17, 1993
Days to Decision 49 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 89d · This submission: 49d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LYA Splint, Intranasal Septal
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 874.4780
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LYA Splint, Intranasal Septal

All 10
Devices cleared under the same product code (LYA) and FDA review panel - the closest regulatory comparables to K933152.
SPIWay Endonasal Access Guide
K180141 · Spiway, LLC · Feb 2018
NOVASHIELD INJECTABLE NASAL PACKING AND STENT
K141704 · Medtronic, Inc. · Oct 2014
NASAL SEPTAL SPLINT
K952207 · Smith & Nephew Richards, Inc. · Jun 1995
NASAL SEPTAL SPLINT
K921195 · Smith & Nephew Richards, Inc. · Jul 1992
TURBINATE NASAL SPLINT
K921202 · Smith & Nephew Richards, Inc. · Jul 1992